ICOS to participate in upcoming conference on Healthcare
February 22, 2006

ICOS Corporation, the maker of famous erectile dysfunction drug Cialis has made an announcement today that it will participate in the Cowen & Co. Healthcare Conference on Thursday, March 9, 2006. The presentation is likely to include a discussion of financial guidance and future plans. It will be webcast. For additional information, you can refer to the website www.icos.com.

ICOS Corporation, the maker of ED drug Cialis, is a biotechnology company headquartered in Bothell, Washington. It is dedicated to bringing innovative therapeutics to patients. Through Lilly ICOS LLC, ICOS is marketing its first product, Cialis® (tadalafil), for the treatment of erectile dysfunction. ICOS is working to develop treatments for serious unmet medical needs such as benign prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer and inflammatory diseases.

To read more, visit….. http://biz.yahoo.com/bw/060222/20060222006089.html?.v=1